Walleye Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Walleye Capital's DXCM Position: Q3 2026 in Review
Walleye Capital increased its DexCom (DXCM) stake by 20,096% in Q3 2026, buying an estimated $3.76M and bringing the position to 45,441 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2147.
Walleye Capital first reported a position in DXCM in Q1 2019 and has held it in 22 quarters since. The position peaked at $61.4M in Q4 2025. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Walleye Capital held 45,441 shares of DexCom worth $3.92M as of Q3 2026.
- Walleye Capital bought 45,216 DexCom shares in Q3 2026, an estimated $3.76M.
- DexCom made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2147 holding.
- Walleye Capital first reported a position in DexCom in Q1 2019 and has held it in 22 quarters since.
- Walleye Capital's DexCom position peaked at $61.4M in Q4 2025.
- 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.